SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-001522
Filing Date
2023-01-09
Accepted
2023-01-09 09:00:13
Documents
14
Period of Report
2023-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171392-8k_somalogic.htm   iXBRL 8-K 35279
2 PRESS RELEASE ISSUED BY SOMALOGIC, INC. ON JANUARY 9, 2023 ea171392ex99-1_somalogic.htm EX-99.1 13349
  Complete submission text file 0001213900-23-001522.txt   275096

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE slgc-20230109.xsd EX-101.SCH 4074
4 XBRL DEFINITION FILE slgc-20230109_def.xml EX-101.DEF 26767
5 XBRL LABEL FILE slgc-20230109_lab.xml EX-101.LAB 37000
6 XBRL PRESENTATION FILE slgc-20230109_pre.xml EX-101.PRE 25391
8 EXTRACTED XBRL INSTANCE DOCUMENT ea171392-8k_somalogic_htm.xml XML 5760
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 23516818
SIC: 8731 Services-Commercial Physical & Biological Research